Trial reportSocial cognitive and affective neuroscience2026
Shared effects of the opioid antagonist naltrexone on first-hand and empathic pain.
Trial report in Social cognitive and affective neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Empathy allows us to infer the affective state of another individual and resonate with it. Accumulating evidence suggests that on a neural level, empathizing relies on "shared neural representations", i.e. patterns of neural activation recruited both during the first-hand and the empathic experience of a specific affective state. Studies employing placebo analgesia have shown consistent reductions in behavioral ratings and neural activity for both firsthand and empathic pain. The mechanistic interpretation of such effects, however, remains elusive, as placebo analgesia could exert its effects on empathy either via pharmacological actions or via top-down cognitive processes on pain and empathy beliefs. To address this limitation, this double-blind placebo-controlled study (N = 35, 21 females) administered the opioid antagonist naltrexone and tested its effects on firsthand pain and affective and cognitive ratings of empathy for pain. While we predicted that naltrexone would increase both electrocutaneous and cold pain, as well as cognitive and affective aspects of empathy for pain, the results instead pointed in the other direction. While these hypo- rather than hyperalgesic effects were unexpected, the coherence in their directionality fits with previous findings and suggests the involvement of shared opioidergic mechanisms in the firsthand experience of pain and empathy for pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.